Mepivacaine HCl 3% Plain 1.7 mL Anesthetic Cartridge

Mepivacaine HCl 3% Plain (1.7 mL) is a potent amide-type local anesthetic supplied in a dental cartridge. Each carpule contains 3% mepivacaine hydrochloride (30 mg/mL) at approximately 51 mg per 1.7 mL dose. It provides rapid-onset, intermediate-duration anesthesia (typically about 2–2.5 hours of pulpal block) without added vasoconstrictor. As a plain (no-epinephrine) formulation, it’s ideal for patients in whom epinephrine is contraindicated. Mepivacaine works by blocking the generation and conduction of nerve impulses – it raises the threshold for electrical excitation in nerve fibers and slows the rate of rise of the action potential. In practice, this means sensory signals (especially pain) cannot be transmitted to the brain, achieving effective numbness for dental and minor surgical procedures.

• Key Features: Each cartridge (tan band) contains 3% mepivacaine HCl in 1.7 mL. No vasoconstrictor (plain). Fast onset (on par or faster than many lidocaine solutions. Duration ~2–2.5 hours of pulpal anesthesia. Packaged 50 cartridges/box.

• INDICATIONS: Mepivacaine HCl 3% is used for local anesthesia by infiltration or nerve block in dentistry and oral surgery. It is suitable for restorative work, periodontal procedures, endodontics (root canals), minor oral surgery, and for any dental patient requiring anesthesia (especially cardiac or hyperthyroid patients) without added epinephrine.

• Onset & Duration: Compared to lidocaine, 3% mepivacaine (plain) generally produces a faster onset of pulpal anesthesia. Clinical studies show mepivacaine’s anesthesia sets in quicker than 2% lidocaine with epinephrine and provides comparable pain control. Mepivacaine’s duration (about 2–3 hours) covers most routine dental procedures.

Mechanism of Action

Mepivacaine is an amide local anesthetic that blocks nerve conduction. It inhibits voltage-gated sodium channels in nerve membranes, increasing the excitation threshold and slowing impulse propagation. This blockade prevents nerve fibers from transmitting pain signals. Clinically, sensory loss typically follows the order: pain is lost first, followed by temperature, touch, and finally pressure. In effect, mepivacaine produces reversible numbness of the targeted area. (This mechanism is similar to other local anesthetics like lidocaine.)

Mepivacaine vs Lidocaine

When comparing mepivacaine to lidocaine, mepivacaine (especially in 3% plain form) often has a faster onset while maintaining similar anesthetic efficacy. In one meta-analysis, 3% plain mepivacaine provided a significantly shorter onset of pulpal anesthesia than 2% lidocaine with epinephrine. Both drugs produce comparable anesthesia, but mepivacaine’s lack of vasodilating effect means it can be used without epinephrine and still achieve adequate duration. Mepivacaine also tends to cause less tachycardia than epinephrine-containing solutions, making it advantageous for cardiac-compromised patients. In short, mepivacaine vs lidocaine: mepivacaine’s onset is equal or faster, and it offers a safe alternative when epinephrine is not desired.

Dosage Guidelines (Mepivacaine dosage)

Dosage of mepivacaine is weight- and procedure-dependent. Each cartridge (1.7 mL of 3%) contains ~51 mg mepivacaine. Professional guidelines recommend a maximum of about 6.6 mg/kg (up to ~400 mg) for healthy adults. For example, an adult patient (70 kg) could receive up to ~460 mg mepivacaine (roughly 9 cartridges) in total, though in practice dentists use the minimum effective dose. Clinicians calculate the needed dose by number of carpules (one carpule = 51 mg). Since this product is preservative-free, multiple cartridges can be given without concern for preservatives. (Always follow standard dosing protocols and patient monitoring.)

Brand Names & Synonyms

Mepivacaine is sold under various brand names. Common mepivacaine brand names include Carbocaine (Pfizer), Polocaine (injection solution, including Polocaine-MPF which is preservative-free), Scandonest (3% plain), and Isocaine. On dental labels and charts, mepivacaine (3% plain) is often tan-colored. These brands all contain the same active ingredient (mepivacaine HCl) and offer 3% concentrations similar to the Henry Schein cartridge. (For instance, Carbocaine 3% is a well-known equivalent to this product.)

Side Effects & Precautions (Mepivacaine side effects)

When used correctly for local anesthesia, mepivacaine is generally safe. Common side effects (mepivacaine side effects) are usually mild and result from systemic absorption:

• Central Nervous System: Patients may experience transient nervousness, dizziness, headache, or tremors. Feeling of restlessness, anxiety, or even depression (drowsiness) can occur at higher doses.
• Sensory: Some report blurred vision or ringing in the ears (tinnitus) during or after injection. These effects are typically short-lived.
• Cardiovascular: Rarely, large doses can cause CNS excitatory symptoms (tremors, convulsions) followed by CNS depression and cardiovascular changes. Toxic levels depress cardiac conduction, potentially causing bradycardia or arrhythmias. However, these severe events are very uncommon when doses stay within guidelines.
• Allergic reactions: True allergy to amide anesthetics like mepivacaine is extremely rare. In sensitive individuals, allergic signs (hives, swelling) would warrant stopping use. This 3% plain formulation contains no sulfite preservative or vasopressor, minimizing allergenic risk.

Precautions: Use only when local anesthesia is indicated, and aspirate carefully to avoid intravascular injection. Monitor patient vitals during use. Mepivacaine should be administered by qualified practitioners.

Note: This cartridge product is for professional use in medical/dental settings only. Always follow institutional protocols for anesthesia administration.